Researcher Profiles

Return to member profile

Sharad Goyal, MD

Selected Publications

  1. Halyard MY, Harris EE, Bailey L, Bellon JR, Freedman GM, Goyal S, Horst KC, Moran MS, Park CC, Suh WW, Toppmeyer D, Haffty BG. ACR Appropriateness criteria local-regional recurrence (LRR) and salvage surgery-breast cancer. Oncology (Williston Park). 2014 Feb;28(2):157-64, C3.
  2. Goyal S, Daroui P, Kearney T, Kirstein L, Haffty BG.  3 year outcomes of a Novel Fractionation Scheme in Accelerated Partial Breast Irradiation (APBI) Using 3-D Conformal Radiotherapy (3D-CRT). Cancer Medicine.  2013 Dec;2(6):964-71.
  3. Pirmalata A, Ferro A, Yue NJ, Haffty BG, Goyal S. Optimization of Surgical Clip Placement for Breast-Conservation Therapy. Pract Radiat Oncol. 2013 Sept 4 (E-pub).
  4. Yue NJ, Goyal S, Kim LH, Khan AJ, Haffty BG.  Patterns of Intra-fractional Motion and Uncertainties of Treatment Setup Reference Systems In Accelerated Partial Breast Irradiation for Right- and Left-sided Breast Cancer. Pract Radiat Oncol. 2013 Feb 4. E-pub.
  5. Yue NJ, Haffty BG, Kearney T, Chen S, Haffty BG, Goyal S.  Tracking the Dynamic Seroma Cavity using Fiducial Markers in Patients Treated with 3-D Conformal Radiotherapy (3D-CRT) Accelerated Partial Breast Irradiation (APBI)). Med Phys. 2013 Feb;40(2):021717.
  6. Goyal S, Shah S, Khan AJ, Danish H, Haffty BG.  Evaluation of Acute Toxicity in Patients Treated With Concurrent Pazopanib & Radiotherapy. IRSN Oncology. Epub 2012 Dec 6.
  7. Shaikh T, Narra V, Goyal S, Ahlawat S, Kirstein L, Kearney TK, Haffty BG, Khan AJ.  Type of Lumpectomy Cavity Closure Does Not Affect Absolute Target Volume or Normal Tissue Dosimetry. Ann Surg Oncol. 2012 Dec 11.
  8. Levinson LL, Yue NJ, Zhou J, Chen T, Goyal S. Determination of Optimal Fiducial Marker Across Image Guided Radiation Therapy (IGRT) Modalities:  Visibility and Artifact Analysis of Gold, Carbon, and Polymer Fiducial Markers. J Clin App Med Phys. 2012; 13(5): 3976.
  9. Daroui P, Gabel M, Khan AJ, Haffty BG, Goyal S.  Utilization of Breast Conserving Therapy in Stage 0, I, II Breast Cancer Patients in New Jersey: An American College of Surgeons National Cancer Data Base (NCDB) Analysis. Am J Clin Oncol. 2012;35(2):130-5.
  10. Taunk NK, Goyal S, Wu H, Moran MS, Chen S, Haffty BG.  DEAD box 1 (DDX1) Expression Predicts for Local Control and Overall Survival in Early Stage, Node Negative Breast Cancer.  Cancer.  2011; 118(4):888-98.
  11. Goyal S, Vicini F, Beitsch P, Kuerer H, Keitsch M, Motwani S, Jeruss J, Lyden M, Haffty BG. Ductal Carcinoma in situ (DCIS) Treated with Breast Conserving Surgery & Accelerated Partial Breast Irradiation (APBI): Comparison of the Mammosite Registry Trial with Intergroup E5194.  Cancer. 2011; 117(6):1149-55.
  12. Taunk NK, Haffty BG, Goyal S. Radiation Recall Five Years after Whole Breast Irradiation for Early Stage Breast Cancer Secondary to Initiation of Rosuvastatin & Amlodipine.  J Clin Oncol.  2011; Jun 6 (E-Pub).
  13. Shaikh T, Chen T, Khan AJ, Yue NJ, Kearney T, Cohler A, Haffty BG, Goyal S.  Improvement in Inter-Observer Accuracy in Delineation of the Lumpectomy Cavity Using Fiducial Markers. Int J Radiat Oncol Biol Phys. 2010; 78(4):1127-34.
  14. Haffty BG & Goyal S.  Molecular Subtyping of Breast Cancer: Implications for Radiation Therapy.  Int J Radiat Oncol Biol Phys. 2010; 77(5):1293-1295.
  15. Rao M, Khan AJ, Moran MS, Hirshfield KM, Ganesan S, Haffty BG, Goyal S.  Clinicopathologic Presentation of Asian-Indian American (AIA) Women with Stage 0, I & II Breast Cancer. J Immigr Minor Health. 2011;13(1):42-8.
  16. Goyal S, Rao M, Khan AJ, Huzzy L, Mcdonald C, Haffty BG.  Evaluation of Acute Toxicity in Patients Treated With Concurrent Bevacizumab & Radiotherapy. Int J Radiat Oncol Biol Phys. 2011; 79(2):408-13.
  17. Taunk N, Goyal S, Yang Q, Moran MS, Parikh RR, Haffty BG.  Prognostic significance of IGF-1R expression in patients treated with breast conserving surgery and radiation therapy.  Radiother Oncol. 2010; 96(2):204-8.
  18. Goyal S, Khan AJ, Vicini F, Beitsch P, Lyden M, Keitsch M, Haffty BG. Factors Associated with Optimal Cosmetic Results in Patients Treated With Accelerated Partial Breast Irradiation (APBI) by the American Society of Breast Surgeons (ASBS) MammoSite® Breast Brachytherapy Registry Trial. Ann Surg Oncol. 2009; 16(9):2450-8.